期刊文献+

醛固酮合成酶基因CYP11B2(-344T/C)多态性对北京汉族高血压患者RAAS系统的影响 被引量:8

The Influence of Gene Polymorphism of Aldosterone Synthase Gene CYP11B2 (-344T/C) on RAAS in Han Nationality Essential Hypertensive Patients in Beijing
下载PDF
导出
摘要 目的探讨醛固酮合成酶基因CYP11B2(-344T/C)多态性对北京汉族高血压患者肾素血管紧张素醛固酮(RAAS)系统的影响。方法采用多聚酶链式反应结合限制性内切酶片段长度多态性分析方法,检测345例原发性高血压(EH)病人和156例健康人(NE)醛固酮合成酶基因CYP11B2(-344T/C)多态性。并对2组人群的血压及各项临床指标和RAAS指标进行测定。结果EH组CC+CT基因型频率显著高于NE组;EH组C等位基因频率显著高于NE组(P<0·01)。在EH组中CC+CT基因型的ALD及ALD/REN显著高于TT基因型(P<0·05);2组间REN及ATⅡ差异无统计学意义(P>0·05);CC+CT基因型的ALD/REN显著高于TT基因型(P<0·05)。结论北京汉族人群中醛固酮合成酶基因CYP11B2(-344T/C)多态性与原发性高血压明显相关,并且对高血压患者的RAAS系统有显著影响。 Objective To evaluate the influence of gene polymorphism of aldosterone synthase gene CYP11B2(-344T/C) on RAAS in Han Nationality essential hypertensive patients in Beijing. Methods Polymerase chain reaction was used to detect the polymorphism of aldosterone synthase gene CYP11B2(-344T/C) in 345 hypertensive patients (EH) and 156 normotensive controls (NE). Clinic blood pressure, biochemical indexes, the indexes of renin angiotensin-aldosterone system were also detected. Results The frequencies of CC+CT genotype of aldosterone synthase gene CYP11B2(-344T/C) polymorphism among EH was significantly higher than that among NE(P〈 0.05), the C allele of CYP11B2 (-344T/C) polymorphism among EH was significantly higher than that among NE(P 〈 0. 01). ALD and ALD/REN of CC+CT genotype of CYP11B2 (-344T/C) polymorphism were significantly higher than TT genotype(P〈0.05). There were no significant difference in REN and AT Ⅱ. Conclusion The CYP11B2 (-344T/C) polymorphism could significantly influence the RAAS in Han Nationality essential hypertensive patients in Beijing.
出处 《首都医科大学学报》 CAS 2006年第3期361-364,共4页 Journal of Capital Medical University
关键词 原发性高血压 醛固酮合成酶 基因多态性 肾素-血管紧张素-醛固酮系统 essential hypertension aldosterone synthase gene polymorphism renin-angiotensin-aldosterone system
  • 相关文献

参考文献10

  • 1Zhang G,Miller W L.The human genome contains only two CYP11B (P450c11) genes[J].J Clin Endocrinol Metab,1996,81:3254-3256.
  • 2Shinji.Genetic polymorphism of CYP11B2gene and hypertension in Japanese[J].Hypertension,1999,33:266-270.
  • 3Clyne C D,Zhang Y,Slutsker L,et al.Angiotnsion Ⅱand potassium regulate human CYP11B2 transcriptionthrough common elements[J].J Clin Endocrinol Metab,1997,11:638-649.
  • 4Hautanen A,Toivanen P,Manttari M,et al.Jointeffects of an aldosterone synthase (CYP11B2) genepolymorphism and classic risk factors on risk of myocar-dial infarction[J].Circulation,1999,100:2213-2218.
  • 5Tamaki S,Iwain N,Tsujita Y,et al.Geneticpolymorphism of CYP11B2 gene and hypertension inJapanese[J].Hypertension,1999,33:266-270.
  • 6孙晓健,侯晓菲,刘少荣,刘文波,陶志刚,李建远.醛固酮合成酶基因-344T/C多态性与山东省汉族人原发性高血压相关性[J].中华医学遗传学杂志,2004,21(5):502-504. 被引量:33
  • 7Francoise Paillard,Dominique Chansel,Eva Brand,etal.Genotype-Phenotype Relationships for the Reningiotensin-Aldosterone System in a Normal Population[J].Hypertension,1999,34:423-429.
  • 8陈爱华,张文秀,唐晓明,李志樑,陆青,钱学贤.醛固酮合成酶基因多态性与高血压及左室肥厚的关系[J].中华内科杂志,2002,41(5):298-301. 被引量:38
  • 9White P C,Hautanen A,Kupari M.Aldosterone synthase (CYP11B2) polymorphisms and cardiovascularfunction[J].Mol Biol,1999,69:409-412.
  • 10Pojoga L,Gantier S,Blanc H,et al.Genetic determination of plasma aldosterone levels in essential hypertension[J].Am J Hypertens,1998,11:856-860.

二级参考文献17

  • 1Devereux RB, Koren MJ, de Simone G, et al. Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease. Eur Heart J ,1993, 14 Suppl D:8-15.
  • 2Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.J Clin Invest, 1990 , 86:1343-1346.
  • 3Kupari M, Hautanen A, Lankinen L, et al. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation, 1998,97:569-575.
  • 4Brand E, Chatelain N, Mulatero P, et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension, 1998,32:198-204.
  • 5Tamaki S,Iwai N,Tsujita Y, et al. Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension, 1999, 33:266-270.
  • 6Hautanen A, Toivanen P, Manttari M,et al. Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction.Circulation, 1999,100:2213-2218.
  • 7Tsujita Y, Iwai N, Katsuya T, et al. Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: the Suita Study. Hypertens Res, 2001, 24:105-109.
  • 8White PC, Hautanen A, Kupari M. Aldosterone synthase (CYP11B2) polymorphisms and cardiovascular function. J Steroid Biochem Mol Biol, 1999,69:409-412.
  • 9Young M, Fullerton M, Dilley R, et al. Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest, 1994, 93:2578-2583.
  • 10Kupari M,Hautanen A,Lankinen L,et al. Associations between human aldosterone synthase gene(CYP11B2) polymorphisms and left ventricular size,mass,and function. Circulation, 1998,97:569-575.

共引文献55

同被引文献99

引证文献8

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部